ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Recruiting now · Not applicable
Conditions studied: Acute Myeloid Leukemia
In brief
The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by evaluating the impact of systematic financial navigation in addition to standard financial distress interventions during cancer treatment.
Key facts
- Study ID
- NCT06945042
- Run by
- Wake Forest University Health Sciences
- People needed
- 120
- Starts
- 2025-06-27
- Expected to finish
- 2028-05-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to understand and willingness to sign an IRB-approved informed consent.
- Age 18-64 years at the time of consent
- Initial diagnosis of Acute Myeloid Leukemia (AML) per investigator Note: Date of initial diagnosis is the date of the bone marrow biopsy
- Planned intensive induction chemotherapy Note: It is acceptable if chemotherapy has been initiated at the time of enrollment as long as it is within 30 days of therapy initiation
- Ability to read and understand the English and/or Spanish language(s)
- As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
You may not qualify if…
- Diagnosis of Acute Promyelocytic Leukemia
- Unwilling to receive induction chemotherapy for AML
- Previous treatment for hematologic malignancy
- Prior allogeneic hematopoietic stem cell transplant
Where it is running
- Levine Cancer Insitute — Charlotte, North Carolina, United States (enrolling)
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.